Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$606.7K
13K shares
What this filing means
GARLAND J. SCOTT plans to sell 13K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $606.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001950047-26-009907
Director
Since Feb 2026
13K
Shares to sell
$606.7K
Approx. market value
13K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/1/2026
13KTotal acquired13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | Stock Option Exercise Cash | 13K | — |
| Total | 13K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13K
Market value
$606.7K
10/1/2026
Total
Units
13K
Value
$606.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/1/2026 | 13K | $606.7K | NASDAQ | Planned |
| Total | 13K | $606.7K | ||